Articles
16 April 2009Mergers & Aquisitions in the Pharmaceuticals Sector 2009
Which pharmaceutical companies are likely to be involved in mega-M&A?
A wave of major M&A deals has reshaped the pharmaceutical industry and may continue as other companies challenge Pfizer’s current dominance
09 November 2008
URCH Publishing provides a review of the global pharmaceutical market in 2008
US growth falls behind Europe as patent expiries bite28 September 2008
New Drug Regulations in China Should Improve Drug Safety and Help Curb Corruption
2007 Drug Registration Procedure will also support Pharma R&D10 February 2008
Wholesalers Threatened as Big Pharma Adopts Direct-to-Pharmacy Drug Distribution Model
The traditional model of pharmaceutical distribution is under threat in Europe, and the UK is seeing the first of the changes, finds new research12 January 2008
Small molecule pharmaceuticals dominate pharmaceutical product approvals
Almost 85% of all novel pharmaceutical products approved globally between 2004 and 2006 were small molecule pharmaceutical drugs, says new research.10 October 2007
Increasing Competition will force Generic Drug Companies to Consolidate or Perish
New market opportunities are potentially offered by the development of biosimilars23 August 2007
Takeda's Blopress to be Leading Cardiovascular Drug By 2011
Global cardiovascular market will grow to $116.3bn by 201005 June 2007
CNS Drug Market Set for Shake Up
GSK to Climb and J&J Fall in Top 10 list06 February 2007
Generics to slash Big Pharma's Revenue by over $100bn in U.S and Europe by 2011
Loss of patent protection for key drugs provides generics opportunity of at least $20bn in 2007, 2008, 2010 and 201126 March 2006